Aptar Collaborates With Massachusetts General Hospital To Advance Nose-To-Brain Drug Delivery And Accelerate CNS Pipelines
Goal is to help pharmaceutical innovators evaluate opportunities earlier and accelerate future central nervous system pipelinesAptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection
Aptar is working with a hospital to help deliver medicines to the brain. This shows the company is investing in new technology that drug makers might want to use.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.